Vinpocetine

Vinpocetine

SCHEMBL50081

CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1A P54750 18/20 1.00
MEN1 O00255 2/20 1.00
LMNA P02545 2/20 1.00
KMT2A Q03164 2/20 1.00
HIF1A Q16665 2/20 1.00
CYP3A4 P08684 2/20 1.00
KDM4E B2RXH2 1/20 1.00
NR1I2 O75469 1/20 1.00
ALDH1A1 P00352 1/20 1.00
CHRM2 P08172 1/20 1.00
ADRA2A P08913 1/20 1.00
MAPT P10636 1/20 1.00
ADRA2B P18089 1/20 1.00
ADRA2C P18825 1/20 1.00
ADORA1 P30542 1/20 1.00
SLC6A4 P31645 1/20 1.00
DRD3 P35462 1/20 1.00
HTR2B P41595 1/20 1.00
BLM P54132 1/20 1.00
PDE1B Q01064 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vinpocetine SCHEMBL29364972 1.00 PDE1A (1.00) PDE1AMEN1LMNAKMT2AHIF1A
Vinpocetine SCHEMBL6246968 1.00 PDE1A (1.00) PDE1AMEN1LMNAKMT2AHIF1A
Vinpocetine SCHEMBL10571708 1.00 PDE1A (1.00) PDE1AMEN1LMNAKMT2AHIF1A
Vinpocetine SCHEMBL20077503 1.00 PDE1A (1.00) PDE1AMEN1LMNAKMT2AHIF1A
Vinpocetine SCHEMBL7947532 1.00 PDE1A (1.00) PDE1AMEN1LMNAKMT2AHIF1A
Vinpocetine SCHEMBL20077534 1.00 PDE1A (1.00) PDE1AMEN1LMNAKMT2AHIF1A
Vinpocetine SCHEMBL160952 1.00 PDE1A (1.00) PDE1AMEN1LMNAKMT2AHIF1A
Vinpocetine SCHEMBL21370424 1.00 PDE1A (1.00) PDE1AMEN1LMNAKMT2AHIF1A
Vinpocetine SCHEMBL21098929 1.00 PDE1A (1.00) PDE1AMEN1LMNAKMT2AHIF1A
Vinpocetine SCHEMBL29366611 1.00 PDE1A (1.00) PDE1AMEN1LMNAKMT2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9536 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746864-A1 C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION Keto Innovations, LLC (US) 2026-05-27 EP claimed
WO-2026090582-A1 COMPOSITIONS CONTAINING A NON-XANTHINE CNS STIMULANT OR NOOTROPIC AND BETA-HYDROXYBUTYRATE OR PRECURSOR FOR INCREASING NEUROLOGICAL AND PHYSIOLOGICAL PERFORMANCE AXCESS GLOBAL SCIENCES, LLC (US) 2026-04-30 WO claimed
EP-4712954-A1 C5 KETONE COMPOSITIONS AND RELATED METHODS FOR THERAPEUTIC AND PERFORMANCE SUPPLEMENTATION Keto Innovations, LLC (US) 2026-03-25 EP claimed
EP-4058037-B1 FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE SPINALCYTE LLC (US) 2026-01-28 EP claimed
US-20250339399-A1 SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) 2025-11-06 US claimed
EP-4642484-A1 TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 EP claimed
EP-4642492-A1 AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 EP claimed
WO-2025106656-A1 METHODS OF PREVENTING OR REDUCING CARTILAGE LOSS AND/OR JOINT DAMAGE USING NAV 1.7 INHIBITORS YALE UNIVERSITY (US) 2025-05-22 WO claimed
CN-119876030-A Composition and method for rapidly reprogramming Cheng Xingxing glial cells as induced neurons 中山大学 2025-04-25 CN claimed
US-12280057-B2 Vasoactive topical compound to affect tissue blood flow, reduce tissue necrosis and promote healing SOUTH DAKOTA BOARD OF REGENTS (US) 2025-04-22 US claimed
EP-0475536-A1 Spherical granules having core and their production Takeda Chemical Industries, Ltd. (JP) 1992-03-18 EP claimed
EP-0202051-B1 THERAPEUTIC COMPOSITIONS FOR ORAL ADMINISTRATION AMERICAN HOME PRODUCTS CORPORATION (US) 1991-08-21 EP claimed
US-4933184-A Menthol enhancement of transdermal drug delivery AMERICAN HOME PRODUCTS CORP. (DEL) (US) 1990-06-12 US claimed
EP-0154756-B1 CITRATE OF VINPOCETINE, AND PROCESS FOR ITS PREPARATION COVEX (S.A.) (ES) 1989-08-16 EP claimed
US-4794001-A CAPSULES CONTAINING SPHEROIDS OR POWDERS; COATED AND UNCOATED AMERICAN HOME PRODUCTS CORPORATION (US) 1988-12-27 US claimed
EP-0277741-A1 Spherical granules having core and their production Takeda Chemical Industries, Ltd. (JP) 1988-08-10 EP claimed
US-4749707-A VASODILATION; CEREBRAL OXYGENATION IN ELDERLY COVEX, S.A. (ES) 1988-06-07 US claimed
US-4686225-A INTRACRANIAL SYNDROMES AMERICAN HOME PRODUCTS CORPORATION (DEL.) (US) 1987-08-11 US claimed
EP-0202051-A2 Therapeutic compositions for oral administration AMERICAN HOME PRODUCTS CORPORATION (US) 1986-11-20 EP claimed
EP-0154756-A1 Citrate of vinpocetine, and process for its preparation COVEX (S.A.) (ES) 1985-09-18 EP claimed